# Long Term Administration of Inhaled Mannitol in Cystic Fibrosis

> **NCT00630812** · PHASE3 · COMPLETED · sponsor: **Syntara** · enrollment: 318 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** inhaled mannitol
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT00630812
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-11
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630812, "Long Term Administration of Inhaled Mannitol in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00630812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*